Eidos Therapeutics, Inc.

Report date
12/31/2020
Quarter
2020 Q4
Filed
1/22/2021
Shares
67,551
Value ($000)
8,889
Weight
0.1%
2019 Q3 - 2020 Q4 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).